Jose R. Rivas Rios M.D. Assistant Professor Department: Department of Medicine Business Email: Jose.RivasRios@jax.ufl.edu Appointments and Locations Board Certifications Internal MedicineCardiovascular Disease Show More Clinical Profile Specialties Cardiovascular Disease Interests Clinical Special Interests: Preventive Cardiology, Cardio-metabolic, Cardiology ImagingResearch Special Interests: Lipids, Antithrombotic Therapy Languages Speaks English and Spanish Show More Publications 2022Aerococcus urinae Infective Endocarditis.Cureus.14(4):e23947-[DOI] 10.7759/cureus.23947.[PMID] 35547451.2 citations·PubMed·Publisher's Site2022New-onset heart failure masking a massive retroperitoneal liposarcoma.Journal of geriatric cardiology : JGC.19(4):319-321[DOI] 10.11909/j.issn.1671-5411.2022.04.003.[PMID] 35572214.PubMed·Publisher's Site2021Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study.BMJ open diabetes research & care.9(1):-[DOI] 10.1136/bmjdrc-2020-001939.[PMID] 33637605.15 citations·PubMed·Publisher's Site2020Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.Thrombosis and haemostasis.120(1):83-93[DOI] 10.1055/s-0039-1695772.[PMID] 31470444.18 citations·PubMed·Publisher's Site2020Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.Journal of the American Heart Association.9(8):e015865-[DOI] 10.1161/JAHA.120.015865.[PMID] 32306797.18 citations·PubMed·Publisher's Site2020Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.JACC. Basic to translational science.5(5):419-428[DOI] 10.1016/j.jacbts.2020.02.009.[PMID] 32478205.24 citations·PubMed·Publisher's Site2019Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.JACC. Cardiovascular interventions.12(16):1538-1549[DOI] 10.1016/j.jcin.2019.05.028.[PMID] 31377269.27 citations·PubMed·Publisher's Site2019Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study.JACC. Basic to translational science.4(7):763-775[DOI] 10.1016/j.jacbts.2019.07.011.[PMID] 31998847.12 citations·PubMed·Publisher's Site2018Diabetes and antiplatelet therapy: from bench to bedside.Cardiovascular diagnosis and therapy.8(5):594-609[DOI] 10.21037/cdt.2018.05.09.[PMID] 30498684.40 citations·PubMed·Publisher's Site2018Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.Circulation.137(23):2450-2462[DOI] 10.1161/CIRCULATIONAHA.118.033983.[PMID] 29526833.43 citations·PubMed·Publisher's Site2018Role of genetic testing in patients undergoing percutaneous coronary intervention.Expert review of clinical pharmacology.11(2):151-164[DOI] 10.1080/17512433.2017.1353909.[PMID] 28689434.50 citations·PubMed·Publisher's Site Show More Office Information Academic Office Jose.RivasRios@jax.ufl.edu Show More Education Medical DegreeUniversidad del Zulia,, Maracaibo, VenezuelaInternal Medicine Residency2020 · University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USACardiovascular Disease Fellowship2023 · University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USA Show More